​

CME Group (CME) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CME Stock Forecast

CME Group (CME) stock forecast, based on 35 Wall Street analysts, predicts a 12-month average price target of $311.83, with a high of $340.00 and a low of $300.00. This represents a 0.21% increase from the last price of $311.19.

$150 $190 $230 $270 $310 $350 High: $340 Avg: $311.83 Low: $300 Last Closed Price: $311.19

CME Stock Rating

CME Group stock's rating consensus is Hold, based on 35 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (37.14%), 17 Hold (48.57%), 5 Sell (14.29%), and 0 Strong Sell (0.00%).

Hold
Total 35 0 5 17 13 Strong Sell Sell Hold Buy Strong Buy

CME Price Target Upside V Benchmarks

TypeNameUpside
StockCME Group0.21%
SectorFinancial Services Stocks 14.67%
IndustryFinancial Data & Stock Exchanges Stocks26.67%
IdeaBlockchain Stocks List29.92%
IdeaCrypto Stocks List44.09%

Price Target Trends

1M3M12M
# Anlaysts-615
Avg Price Target-$317.17$305.53
Last Closing Price$311.19$311.19$311.19
Upside/Downside-1.92%-1.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 263441315
Feb, 263441315
Jan, 263361215
Dec, 253361215
Nov, 253571218
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 06, 2026UBS$310.00$297.384.24%-0.38%
Feb 05, 2026Ashish SabadraRBC Capital$302.00$300.420.53%-2.95%
Feb 05, 2026Morgan Stanley$340.00$294.6215.40%9.26%
Feb 05, 2026Benjamin BudishBarclays$312.00$294.625.90%0.26%
Jan 15, 2026Morgan Stanley$319.00$273.4116.67%2.51%
Dec 22, 2025Michael CyprysMorgan Stanley$320.00$269.0918.92%2.83%
Dec 12, 2025Barclays$304.00$272.4211.59%-2.31%
Oct 23, 2025Michael CyprysMorgan Stanley$314.00$269.5016.51%0.90%
Oct 23, 2025Alex KrammUBS$280.00$267.814.55%-10.02%
Oct 23, 2025Deutsche Bank$300.00$269.5911.28%-3.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 06, 2026UBSNeutralNeutralhold
Feb 05, 2026RBC CapitalSector PerformSector Performhold
Feb 05, 2026Cowen & Co.BuyBuyhold
Feb 05, 2026Morgan StanleyOverweightOverweighthold
Jan 14, 2026Cowen & Co.HoldBuyupgrade
Jan 06, 2026UBSNeutralNeutralhold
Dec 22, 2025Morgan StanleyOverweightOverweighthold
Oct 23, 2025Morgan StanleyOverweightOverweighthold
Oct 23, 2025UBSNeutralNeutralhold
Oct 23, 2025Deutsche BankHoldBuyupgrade

Financial Forecast

EPS Forecast

$6 $7 $8 $9 $10 $11 $12 $13 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.30$7.41$8.87$9.69$11.18---
Avg Forecast$6.68$7.94$9.25$10.19$10.39$10.93$11.66$12.60
High Forecast$6.93$8.15$9.31$10.23$10.65$11.67$12.50$12.98
Low Forecast$6.42$7.59$9.21$10.15$10.09$9.82$10.82$12.04
Surprise %9.28%-6.68%-4.11%-4.91%7.60%---

Revenue Forecast

$5B $5B $6B $7B $7B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.69B$5.02B$5.58B$6.13B$6.52B---
Avg Forecast$4.71B$5.02B$5.57B$6.11B$6.28B$6.57B$6.94B$7.39B
High Forecast$4.84B$5.13B$5.58B$6.12B$6.41B$6.59B$7.04B$7.56B
Low Forecast$4.57B$4.85B$5.55B$6.10B$6.15B$6.56B$6.84B$7.14B
Surprise %-0.35%-0.02%0.16%0.26%3.89%---

Net Income Forecast

$2B $3B $3B $4B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.64B$2.69B$3.23B$3.53B$4.04B---
Avg Forecast$2.58B$3.00B$3.19B$3.66B$3.73B$3.69B$4.19B$4.53B
High Forecast$3.09B$3.60B$3.82B$3.68B$3.83B$4.19B$4.49B$4.67B
Low Forecast$2.06B$2.40B$2.55B$3.65B$3.63B$3.53B$3.89B$4.33B
Surprise %2.35%-10.20%1.27%-3.75%8.52%---

CME Forecast FAQ

Is CME Group stock a buy?

CME Group stock has a consensus rating of Hold, based on 35 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 17 Hold, 5 Sell, and 0 Strong Sell, reflecting a consensus that CME Group is a neutral investment for most analysts.

What is CME Group's price target?

CME Group's price target, set by 35 Wall Street analysts, averages $311.83 over the next 12 months. The price target range spans from $300 at the low end to $340 at the high end, suggesting a potential 0.21% change from the previous closing price of $311.19.

How does CME Group stock forecast compare to its benchmarks?

CME Group's stock forecast shows a 0.21% upside, underperforming the average forecast for the financial services stocks sector (14.67%) and underperforming the financial data & stock exchanges stocks industry (26.67%), trailing the Blockchain Stocks List (29.92%) and Crypto Stocks List (44.09%) investment ideas.

What is the breakdown of analyst ratings for CME Group over the past three months?

  • March 2026: 20.00% Strong Buy, 26.67% Buy, 26.67% Hold, 6.67% Sell, 20.00% Strong Sell.
  • February 2026: 20.00% Strong Buy, 26.67% Buy, 26.67% Hold, 6.67% Sell, 20.00% Strong Sell.
  • January 2026: 20.00% Strong Buy, 20.00% Buy, 40.00% Hold, 6.67% Sell, 13.33% Strong Sell.

What is CME Group’s EPS forecast?

CME Group's average annual EPS forecast for its fiscal year ending in December 2026 is $10.93, marking a -2.24% decrease from the reported $11.18 in 2025. Estimates for the following years are $11.66 in 2027, and $12.6 in 2028.

What is CME Group’s revenue forecast?

CME Group's average annual revenue forecast for its fiscal year ending in December 2026 is $6.57B, reflecting a 0.83% increase from the reported $6.52B in 2025. The forecast for 2027 is $6.94B, and $7.39B for 2028.

What is CME Group’s net income forecast?

CME Group's net income forecast for the fiscal year ending in December 2026 stands at $3.69B, representing a -8.73% decrease from the reported $4.04B in 2025. Projections indicate $4.19B in 2027, and $4.53B in 2028.